About

BioAgilytix offers specialized bioanalytical testing services for the pharmaceutical, biotechnology, and agricultural biotechnology industries, focusing on large molecule studies essential for drug development. They provide a range of assays, including pharmacokinetics, pharmacodynamics, cell-based, and immunogenicity assays, to help clients understand drug behavior and safety. With a global presence, particularly in Europe, BioAgilytix distinguishes itself by its expertise in large molecule studies and customizable COVID-19 testing solutions. Their goal is to support life sciences companies in developing and validating new treatments while ensuring product safety.

Simplify's Take

What believers are saying

• Increased demand for personalized medicine boosts need for specialized testing services.
• Growing market for biosimilars and biobetters expands client base opportunities.
• Global cell-based assay market growth aligns with BioAgilytix's expertise.

What critics are saying

• Cancellation of Durham expansion may impact growth and local economic contributions.
• Regulatory challenges may arise in US market for Stockholm3 prostate cancer test.
• Hamburg lab expansion may strain resources, affecting service quality.

What makes BioAgilytix unique

• Specializes in immunoassays and cell-based assays for large molecule studies.
• Operates globally with significant presence in Europe and the US.
• Offers comprehensive suite of assays including PK, PD, and immunogenicity.

Help us improve and share your feedback! Did you find this helpful?

YesNo